Literature DB >> 8828748

Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994.

E Delaporte1, W Janssens, M Peeters, A Buvé, G Dibanga, J L Perret, V Ditsambou, J R Mba, M C Courbot, A Georges, A Bourgeois, B Samb, D Henzel, L Heyndrickx, K Fransen, G van der Groen, B Larouzé.   

Abstract

OBJECTIVE: To describe trends in the prevalence of HIV-1 infection in different populations in Gabon, and the molecular characteristics of circulating HIV strains.
METHODS: Data were collected on HIV prevalence through sentinel surveillance surveys in different populations in Libreville (the capital) and in Franceville. In Libreville, a total of 7082 individuals (hospitalized patients, tuberculosis patients, pregnant women, asymptomatic adults, prisoners) were recruited between 1986 and 1994. In Franceville, we tested 771 pregnant women and 886 healthy asymptomatic adults (1986-1988). Sera were screened for HIV antibodies by enzyme-linked immunosorbent assay (ELISA) and confirmed by Western blot or line immunoassay (LIA). Reactive samples in ELISA were tested for the presence of antibodies to HIV-1 group O viruses by ELISA using V3 peptides from HIV-1 ANT-70 and HIV-1 MVP-5180 followed by confirmation by LIA and a specific Western blot. Seventeen HIV-1 strains were isolated (1988-1993) and a 900 base-pair fragment encoding the env region containing V3, V4, V5 and beginning of gp41 was sequenced and a phylogenetic tree was constructed.
RESULTS: HIV prevalence was relatively low and remained stable (0.7-1.6% in pregnant women, 2.1-2.2% in the general population). The prevalence was also stable among prisoners (2.1-2.6%). Among hospitalized and tuberculosis patients prevalence was higher and increased (1.8-12.7% and 1.5-16.2%, respectively). Only three sera had antibodies to HIV-1 group O. The 17 HIV-1 strains represent six different genetic subtypes including type O.
CONCLUSION: Our data from 1986 to 1994 show a stable and low HIV prevalence in Gabon, and a high genetic diversity of HIV-1 strains. This, also observed in Cameroon, is in contrast to that found elsewhere in Africa. Differences in rate of spread of HIV infection are probably explained by interplay between numerous factors. The role of different HIV subtypes in the dynamics of the HIV epidemic should be examined further.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828748     DOI: 10.1097/00002030-199607000-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

Review 1.  Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Authors:  L Buonaguro; M L Tornesello; F M Buonaguro
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

2.  V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.

Authors:  J C Plantier; F Damond; S Souquières; F Brun-Vézinet; F Simon; F Barin
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 3.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR.

Authors:  Jean-Christophe Plantier; Marie Gueudin; Fabienne de Oliveira; Florence Damond; Véronique Lemée; Françoise Brun-Vézinet; François Simon
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.

Authors:  Nathalie Boutonnet; Wouter Janssens; Carlo Boutton; Jean-Luc Verschelde; Leo Heyndrickx; Els Beirnaert; Guido van der Groen; Ignace Lasters
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1.

Authors:  Simon A A Travers; Jonathan P Clewley; Judith R Glynn; Paul E M Fine; Amelia C Crampin; Felix Sibande; Dominic Mulawa; James O McInerney; Grace P McCormack
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 7.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

8.  Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa.

Authors:  Mélanie Caron; Sonia Etenna Lekana-Douki; Maria Makuwa; Guy-Patrick Obiang-Ndong; Olivia Biba; Dieudonné Nkoghé; Mirdad Kazanji
Journal:  BMC Infect Dis       Date:  2012-03-20       Impact factor: 3.090

Review 9.  Roles and functions of HIV-1 Tat protein in the CNS: an overview.

Authors:  Asen Bagashev; Bassel E Sawaya
Journal:  Virol J       Date:  2013-12-21       Impact factor: 4.099

Review 10.  What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Authors:  Grant R Campbell; Erwann P Loret
Journal:  Retrovirology       Date:  2009-05-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.